|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.78 USD | +31.81% |
|
+28.58% | +44.91% |
| Apr. 29 | Zoetis to Sell Medicated-Feed-Additive Portfolio to Phibro for $350 Million | DJ |
| Apr. 29 | Zoetis to Sell Medicated Feed Additives Business to Phibro Animal Health for $350 Million | MT |
Phibro Animal Health Corporation reported earnings results for the fourth quarter ended June 30, 2023. For the fourth quarter, the company reported sales was USD 255 million compared to USD 255.3 million a year ago. Net income was USD 11.5 million compared to USD 7.5 million a year ago.
Basic earnings per share from continuing operations was USD 0.28 compared to USD 0.18 a year ago. Diluted earnings per share from continuing operations was USD 0.28.
| 1st Jan change | Capi. | |
|---|---|---|
| +44.91% | 680M | |
| -19.09% | 72.97B | |
| -8.93% | 6.69B | |
| +21.38% | 3.6B | |
| +1.52% | 1.44B | |
| -16.99% | 1.34B | |
| -7.03% | 1.25B | |
| -26.05% | 1.24B | |
| -12.71% | 1.15B | |
| -4.03% | 1.01B |
PHIBRO ANIMAL HEALTH CORPORATION 
